A Novel Aminopeptidase N/CD13 Inhibitor Selectively Targets an Endothelial Form of CD13 After Coupling to Proteins

Scientists described a novel peptide ligand that recognizes CD13 with high affinity and selectivity. Biochemical studies showed that most CD13 molecules expressed on the surface of ECs are catalytically inactive.